Log in
Enquire now
CellCentric

CellCentric

Developer of p300/CBP small-molecule inhibitor drug to treat cancer.

OverviewStructured DataIssuesContributors

Contents

cellcentric.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Drug delivery
Drug delivery
Pharmaceutical industry
Pharmaceutical industry
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Research and development
Research and development
...
Location
United Kingdom
United Kingdom
Oxford
Oxford
0
Cheshire County, New Hampshire
Cheshire County, New Hampshire
0
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire
0
B2X
B2B
B2B
CEO
Will West
Will West
0
Founder
Will West
Will West
Pitchbook URL
pitchbook.com/profiles.../57078-82
Legal Name
CellCentric Ltd.
Legal classification
Private limited company
Private limited company
Limited company
Limited company
Date Incorporated
October 30, 2003
Spun Out From
University of Cambridge
University of Cambridge
Number of Employees (Ranges)
11 – 50
Email Address
info@cellcentric.com0
Phone Number
+4417995311300
+4416252389100
+4418657845560
Number of Employees
8
Full Address
No. 1 Alderley Park Alderley Edge Cheshire SK10 4TG United Kingdom0
Oxford Science Park Magdalen Centre Oxford OX4 4GA United Kingdom0
Chesterford Research Park, Little Chesterford, Cambridge, CB10 1XL
Chesterford Research Park Little Chesterford Cambridge CB10 1XL England, United Kingdom0
Incorporation Reference
04948632
Investors
‌
Providence Investment Company Limited
Avlar BioVentures
Avlar BioVentures
Morningside Venture Capital
Morningside Venture Capital
Takeda Ventures
Takeda Ventures
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund
Biotechnology and Biological Sciences Research Council
Biotechnology and Biological Sciences Research Council
5Y Capital
5Y Capital
UK Research & Innovation (UKRI)
UK Research & Innovation (UKRI)
...
Founded Date
2003
Total Funding Amount (USD)
243,531,754
Latest Funding Round Date
May 19, 2025
Competitors
‌
CREOSALUS INC.
0
Clovis Oncology
Clovis Oncology
0
ArcherDx
ArcherDx
0
Avexis, Inc.
Avexis, Inc.
0
Akesogen, Inc.
Akesogen, Inc.
0
CFO
‌
Celia Economides
Latest Funding Type
Series C
Series C
Patents Assigned (Count)
3
COO
‌
Debbie Haynes
Country
United Kingdom
United Kingdom
0
Headquarters
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
120,000,000
UKSIC Code
72110
Wikidata ID
Q30255781

CellCentric is a clinical stage biotechnology company that focuses on developing first of its kind, p300/CBP inhibitor for the treatment of specific cancer types.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like CellCentric

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.